(COG ANHL1131) Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
Description: 

For the patients with advanced stage B-Cell NHL/B-AL to test whether adding 6 injections of rituximab to standard LMB chemotherapy regimen improves the EFS compared with LMB chemotherapy alone.

Study Number: 

NCG 221412

Phase: 
II/III
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01595048

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.